NeuroSense Therapeutics (NRSN) Earnings Date & Reports

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRSN is expected to report earnings to fall 79.85% to -3 cents per share on December 02

NeuroSense Therapeutics NRSN Stock Earnings Reports

Q3'26

Est.

$-0.04

Q2'26

Est.

$-0.19

Q4'25

Missed

by $0.13

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.09

The last earnings report on September 02 showed earnings per share of -19 cents, meeting the estimate of -19 cents. With 2.83M shares outstanding, the current market capitalization sits at 19.29M.

View a ticker or compare two or three

NRSN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days